Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now later-stage tilt small index

Cerebral Infarction: later-stage trial registry

2 of 3 indexed Cerebral Infarction trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count

Cerebral Infarction: 3 US clinical trials tracked, 2 recruiting.

Cerebral Infarction is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute of Neurological Disorders and Stroke (NINDS), running 1 of these trials.

Enrollment posture brief

Registry condition cerebral-infarction

OPEN 2 | RECR 67% | LATE 1 | EARLY 0 | RANK #5209 | SPON 1

Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Cerebral Infarction (this)67%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Cerebral Infarction

Cerebral Infarction lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cerebral Infarction on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cerebral Infarction is recruiting above its size-band peers.

    2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Named interventions

Most-linked intervention names on Cerebral Infarction records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

folic acid multivitamin Drug
1 trials
cyanocobalamin Drug
1 trials
pyridoxine Drug
1 trials
Intravenous and Intranasal BMSC Procedure
1 trials

US sites by state

Facility locations filed on Cerebral Infarction trials. A trial with sites in several states counts in each.

North Carolina 1 trials
Florida 1 trials
Connecticut 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cerebral Infarction page

3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cerebral Infarction condition card totals 3 registered trials; most-linked intervention folic acid multivitamin; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.